GO:0001558 regulation of cell growth: Signaling Hub, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0001558 regulation of cell growth describes any process that modulates the frequency, rate, extent or direction of cell growth.
• Cell growth regulation is controlled by conserved signaling pathways including Hippo, Wnt, mTOR, and growth factor cascades [1,5,6].
• Dysregulation of cell growth underlies cancer, cardiac hypertrophy, developmental disorders, and tissue degeneration [1,5,7].
• Key regulatory genes include YAP1, WWTR1, STK3/4, LATS1/2, WNT11, and LKB1 (STK11) [1,5,7].
• CRISPR knockout, point mutation, knock-in, and overexpression models enable causal dissection of growth-regulatory genes [1,5,7].
• Modern methods such as Ribo-seq, RNA-seq, proteomics, and live imaging quantify growth regulation at multiple scales [3,4,8].
Description
Regulation of cell growth (GO:0001558) encompasses any biological process that modulates the frequency, rate, extent, or direction of cell growth. This ontology term is fundamental to understanding how cells, tissues, and organisms coordinate size control with proliferation, differentiation, and environmental cues [1,6]. Cell growth regulation is not a single pathway but an integrated network of signaling cascades, transcriptional programs, and mechanical feedback mechanisms that operate across diverse biological contexts [1,3,5]. In metazoans, the Hippo pathway serves as a central regulator of organ size by phosphorylating and inactivating the YAP/TAZ transcriptional co-activators, thereby restricting cell growth and promoting contact inhibition. Similarly, growth factor signaling through receptors such as FGFR and EGFR controls lens development and tissue growth, while Wnt11 regulates both physiological and pathological cardiac growth. In skeletal muscle, LKB1 (STK11) governs muscle progenitor cell homeostasis and metabolism, linking energy sensing to growth control. Even in plants, stem cell regulation in shoot apical meristems provides evolutionary insight into conserved growth-control principles. For researchers, GO:0001558 provides a structured framework to annotate genes, interpret omics data, and design experiments that test causal roles in growth regulation [1,3,7]. Understanding this term is essential for cancer biology, regenerative medicine, developmental biology, and metabolic disease research [1,5,7].
regulation of cell growth At A Glance
| GO ID | GO:0001558 |
|---|---|
| GO term | regulation of cell growth |
| Ontology | biological_process |
| Synonym | none |
| Major function | Modulates the frequency, rate, extent or direction of cell growth |
| Key pathways | Hippo, Wnt, mTOR, growth factor signaling [1,5,6] |
| Representative genes | YAP1, WWTR1, STK3/4, LATS1/2, WNT11, STK11 [1,5,7] |
| Disease relevance | Cancer, cardiac hypertrophy, developmental disorders, metabolic disease [1,5,7] |
| Research methods | CRISPR screens, Ribo-seq, RNA-seq, proteomics, imaging [3,4,8] |
What Is GO:0001558?
GO:0001558 regulation of cell growth is defined as any process that modulates the frequency, rate, extent or direction of cell growth. In practical terms, it includes signaling events, transcriptional changes, and mechanical inputs that alter how much a cell increases in size or mass over time [1,3]. This term is a biological process and serves as a parent for more specific child terms such as positive regulation of cell growth and negative regulation of cell growth.
Why Is regulation of cell growth Important in Cell Biology?
Regulation of cell growth is central to organismal development, tissue homeostasis, and disease pathogenesis [1,6]. When growth-regulatory pathways malfunction, cells may undergo uncontrolled proliferation, leading to cancer, or inappropriate growth arrest, contributing to degenerative conditions [1,7]. The Hippo pathway exemplifies how growth regulation integrates cell density, mechanical cues, and developmental signals to control organ size. Growth factor signaling pathways, such as those involving FGF and Wnt, are essential for embryonic development and tissue repair [5,6]. In skeletal muscle, LKB1 links energy metabolism to muscle progenitor homeostasis, highlighting the intersection of growth regulation with metabolic health. Understanding GO:0001558 therefore has broad implications for oncology, cardiology, regenerative medicine, and developmental biology [1,5,7].
• Controls organ size and tissue architecture through Hippo pathway-mediated YAP/TAZ inactivation.
• Regulates cardiac growth in both physiological and pathological contexts via Wnt11 signaling.
• Governs lens development and ocular tissue growth through growth factor signaling.
• Maintains skeletal muscle progenitor cell homeostasis and metabolism via LKB1.
• Dysregulation leads to cancer, as YAP/TAZ activation promotes uncontrolled growth.
• Implicated in cardiac hypertrophy and heart failure through Wnt11-dependent mechanisms.
• Provides evolutionary insights into stem cell regulation in land plants.
• Essential for understanding cell contact inhibition and tissue growth control.
• Links energy sensing to growth control through LKB1-AMPK signaling.
• Enables development of targeted therapies for growth-related diseases [1,5,7].
What Happens During regulation of cell growth?
Signal Reception and Integration
In simple terms: Cells receive external and internal signals that tell them whether to grow or stop growing.
Regulation of cell growth begins with the reception of diverse signals, including growth factors, mechanical cues, and nutrient availability [1,6]. Growth factor signaling through receptor tyrosine kinases activates downstream cascades that promote cell growth, as demonstrated in lens development where FGF and other growth factors regulate proliferation and differentiation. The Hippo pathway integrates cell contact and mechanical signals to control organ size by phosphorylating YAP and TAZ, leading to their inactivation and cytoplasmic retention. Wnt11 signaling similarly transduces extracellular cues to regulate cardiac growth in both physiological and pathological settings. These signaling inputs converge on transcriptional programs that determine whether a cell increases in mass or exits the growth cycle [1,5].
Hippo Pathway-Mediated Growth Suppression
In simple terms: The Hippo pathway acts as a brake on cell growth by turning off YAP and TAZ.
The Hippo pathway is a conserved kinase cascade that restricts cell growth and promotes contact inhibition. When activated, STK3/4 (MST1/2) phosphorylate LATS1/2, which in turn phosphorylate YAP and TAZ, causing their cytoplasmic sequestration and degradation. Inactivation of YAP by the Hippo pathway is directly involved in cell contact inhibition and tissue growth control, as shown in studies where YAP inactivation prevents overgrowth. This pathway is critical for maintaining organ size and preventing tumorigenesis.
Growth Factor and Wnt Signaling in Cardiac and Lens Growth
In simple terms: Specific growth factors and Wnt proteins control organ growth in the heart and eye.
Wnt11 plays a dual role in cardiac growth, regulating both physiological hypertrophy and pathological remodeling. In the lens, growth factor signaling controls the precise coordination of cell proliferation, differentiation, and apoptosis that shapes the developing eye. These pathways demonstrate how secreted factors modulate growth in a tissue-specific manner [5,6].
Metabolic and Energy Sensing in Growth Control
In simple terms: Cells check their energy status before committing to growth.
LKB1 (STK11) is a master kinase that regulates skeletal muscle development, metabolism, and muscle progenitor cell homeostasis. By activating AMPK and related pathways, LKB1 couples energy availability to growth decisions, ensuring that cells do not grow when resources are scarce. This metabolic checkpoint is essential for maintaining muscle mass and function.
Apoptosis and Cell Death Regulation in Growth Contexts
In simple terms: Cell growth decisions are balanced by signals that can trigger cell death.
Regulation of cell growth is intimately linked to cell death pathways, as growth factors often provide survival signals. Inhibitor of apoptosis proteins (IAPs) and their antagonists modulate cell death, thereby influencing net tissue growth. The interplay between growth-promoting and death-inducing signals determines whether a cell contributes to tissue expansion or is eliminated.
Evolutionary Conservation in Plant Stem Cells
In simple terms: Plants use similar principles to control stem cell growth in their growing tips.
Studies in bryophytes have revealed fundamental mechanisms of stem cell regulation in land plants, showing that shoot apical cells integrate hormonal and environmental signals to control growth. These findings highlight the deep evolutionary conservation of growth-regulatory logic across kingdoms.
Key Genes Involved in GO:0001558 regulation of cell growth
The following genes and proteins are central to the regulation of cell growth (GO:0001558), as supported by published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| YAP1 | Transcriptional co-activator inactivated by Hippo pathway; promotes cell growth | Oncogene; target for cancer therapy and organ size control |
| WWTR1 (TAZ) | Paralog of YAP; mediates Hippo-dependent growth regulation | Implicated in cancer and tissue regeneration |
| STK3/4 (MST1/2) | Upstream kinases that activate LATS1/2 in Hippo pathway | Tumor suppressors; regulate organ size |
| LATS1/2 | Phosphorylate and inactivate YAP/TAZ | Critical for contact inhibition and growth suppression |
| WNT11 | Regulates physiological and pathological cardiac growth | Therapeutic target for cardiac hypertrophy |
| STK11 (LKB1) | Regulates skeletal muscle development, metabolism, and progenitor homeostasis | Links energy sensing to growth control |
| FGFR | Growth factor receptor controlling lens development | Model for growth factor signaling in organogenesis |
| EGFR | Growth factor receptor regulating cell proliferation and growth | Target in cancer and developmental biology |
| IAPs | Inhibit apoptosis; influence net cell growth | Modulators of cell survival and tissue growth |
| SMAC/DIABLO | Antagonist of IAPs; promotes cell death | Regulates balance between growth and death |
| AMPK | Energy sensor activated by LKB1; inhibits growth under low energy | Metabolic regulator of cell growth |
| mTOR | Central kinase integrating growth signals and nutrient availability | Target for cancer and metabolic diseases |
| CTNNB1 (β-catenin) | Mediates Wnt signaling; promotes growth | Oncogene in multiple cancers |
| MYC | Transcription factor driving cell growth and proliferation | Oncogene; target for growth inhibition |
| CDKN1A (p21) | Cell cycle inhibitor; negative regulator of growth | Tumor suppressor; marker of growth arrest |
| CDKN2A (p16) | Inhibits CDK4/6; restricts cell growth | Tumor suppressor; senescence marker |
| RB1 | Gatekeeper of cell cycle; restricts growth | Tumor suppressor; regulates growth arrest |
| TP53 | Induces growth arrest or apoptosis in response to stress | Master tumor suppressor |
How Is regulation of cell growth Regulated?
Regulation of cell growth (GO:0001558) is itself controlled by multiple layers of regulation. The Hippo pathway is a key upstream regulator that responds to cell density and mechanical cues to phosphorylate and inactivate YAP/TAZ. Growth factor signaling through receptors such as FGFR and EGFR activates downstream cascades including MAPK and PI3K-AKT-mTOR, which promote growth. Wnt11 provides tissue-specific regulation of cardiac growth, with distinct effects in physiological versus pathological contexts. LKB1-AMPK signaling acts as an energy checkpoint, inhibiting growth when ATP levels are low. Additionally, apoptosis regulators such as IAPs and their antagonists modulate the balance between cell survival and death, indirectly influencing net growth. In plants, stem cell regulation in shoot apical meristems involves hormonal and environmental inputs that control growth. Together, these mechanisms ensure that cell growth is tightly coordinated with developmental and metabolic states [1,5,6,7].
regulation of cell growth and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| YAP1 | Cancer (multiple solid tumors) | Knockout and overexpression in cancer cell lines |
| WNT11 | Cardiac hypertrophy and heart failure | Cardiomyocyte-specific knockout and knock-in mouse models |
| STK11 (LKB1) | Peutz-Jeghers syndrome, metabolic disorders | Muscle-specific knockout and point mutation models |
| FGFR | Lens developmental defects, cataracts | Conditional knockout in lens epithelium |
| IAPs | Cancer and neurodegeneration | Knockout and overexpression in neuronal and cancer cells |
Cancer and Uncontrolled Cell Growth
Dysregulation of cell growth regulation is a hallmark of cancer. Inactivation of the Hippo pathway leads to YAP/TAZ activation, promoting uncontrolled proliferation and tumorigenesis. YAP is a potent oncogene, and its inactivation by the Hippo pathway is critical for contact inhibition and tissue growth control. Loss of upstream kinases such as STK3/4 or LATS1/2 results in YAP-driven overgrowth and cancer development. Targeting growth-regulatory pathways is therefore a major therapeutic strategy in oncology.
Cardiac Hypertrophy and Heart Failure
Wnt11 signaling regulates both physiological and pathological cardiac growth. Dysregulated Wnt11 activity contributes to cardiac hypertrophy and heart failure, making it a potential therapeutic target. Understanding how Wnt11 coordinates growth in the heart is essential for developing treatments for cardiomyopathies.
Developmental Disorders and Lens Defects
Growth factor regulation of lens development is critical for proper eye formation. Disruption of FGF or other growth factor signaling leads to lens developmental defects, including cataracts and microphthalmia. These findings highlight the importance of precise growth control during embryogenesis.
Metabolic and Muscle Disorders
LKB1 (STK11) mutations cause Peutz-Jeghers syndrome and are associated with metabolic and muscle disorders. LKB1 regulates skeletal muscle development, metabolism, and muscle progenitor cell homeostasis, linking growth control to energy balance. Dysregulation of this pathway contributes to muscle wasting and metabolic disease.
From regulation of cell growth-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does YAP1 drive tumor growth in vivo? | YAP1 knockout and overexpression in mouse cancer models |
| How does WNT11 regulate cardiac hypertrophy? | Cardiomyocyte-specific WNT11 knockout and knock-in mice |
| What is the role of LKB1 in muscle progenitor homeostasis? | Muscle-specific STK11 knockout and point mutation models |
| How does FGFR signaling control lens growth? | Conditional FGFR knockout in lens epithelium |
| Do IAP antagonists promote cell death in cancer? | IAP knockout and SMAC mimetic overexpression models |
| How do plant stem cells regulate growth? | Bryophyte shoot apical cell knockout and knock-in models |
How to Study the regulation of cell growth Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout screen | Gene essentiality for growth | Identify growth regulators |
| RNA-seq | Transcriptional changes | Map growth-related gene expression |
| Ribo-seq | Translation efficiency | Measure protein synthesis during growth |
| Phosphoproteomics | Kinase substrate phosphorylation | Map Hippo, AMPK, mTOR signaling [1,7] |
| Live-cell imaging | Cell size and division dynamics | Track growth in real time |
| Organoid culture | Tissue-level growth and morphology | Model organ growth and disease [5,6] |
| Western blot | Protein expression and modification | Validate pathway activation [1,7] |
| Immunofluorescence | Protein localization and tissue architecture | Assess YAP/TAZ localization |
CRISPR Screens for Growth Regulators
Genome-wide CRISPR knockout and activation screens enable unbiased discovery of genes that regulate cell growth under specific conditions. These screens can identify positive and negative regulators of growth, including Hippo pathway components and growth factor receptors. Hits are validated using individual knockout or overexpression models.
Transcriptomics and Ribo-seq
RNA sequencing and Ribo-seq measure changes in gene expression and translation that accompany growth regulation [3,8]. These methods reveal transcriptional programs downstream of YAP/TAZ, Wnt, and mTOR signaling [1,5]. Ribo-seq provides codon-level resolution of translation efficiency during growth.
Proteomics and Phosphoproteomics
Mass spectrometry-based proteomics quantifies protein abundance and post-translational modifications in growth-regulatory pathways [4,7]. Phosphoproteomics identifies substrates of kinases such as LATS1/2, AMPK, and mTOR [1,7]. These approaches map signaling networks controlling cell growth [1,7].
Live-Cell Imaging and Organoid Models
Live-cell imaging tracks cell size, division, and growth dynamics in real time [3,6]. Organoid and 3D culture systems model tissue-level growth regulation and drug responses [5,6]. These methods bridge molecular mechanisms and tissue physiology [3,6].
How CRISPR Can Be Used to Study GO:0001558 regulation of cell growth
Knockout
CRISPR knockout of growth-regulatory genes such as YAP1, LATS1/2, or STK11 enables loss-of-function studies to determine their causal role in cell growth [1,7]. Knockout models reveal whether a gene is required for proliferation, contact inhibition, or organ size control. These models are essential for validating hits from CRISPR screens.
Point Mutation
CRISPR point mutation introduces specific amino acid substitutions to dissect phosphorylation sites, catalytic residues, or binding interfaces in growth-regulatory proteins [1,7]. For example, mutating LATS phosphorylation sites on YAP prevents its inactivation, leading to constitutive growth promotion. Point mutation models provide mechanistic insights that knockout alone cannot.
Knock-in
CRISPR knock-in enables precise insertion of reporters, tags, or disease-relevant alleles into endogenous loci [1,5]. Tagged knock-in of YAP or WNT11 allows real-time tracking of protein localization and dynamics during growth [1,5]. Knock-in of patient mutations models disease-associated growth dysregulation [5,7].
Overexpression
CRISPR activation (CRISPRa) or transgenic overexpression of growth-promoting genes such as YAP1, WNT11, or MYC drives excessive cell growth and models oncogenic transformation [1,5]. Overexpression models are useful for gain-of-function studies and drug screening [1,5]. They complement knockout approaches to establish causality.
How EDITGENE Supports regulation of cell growth Research
Researchers studying regulation of cell growth-related genes often need to determine whether a candidate gene is causally involved in growth control, and to dissect the precise molecular mechanisms by which it acts. EDITGENE provides end-to-end CRISPR services to generate knockout, point-mutation, knock-in, and overexpression cell models, as well as CRISPR library screening and bioinformatics support, enabling rigorous functional studies of GO:0001558 and its associated pathways.
Contact EDITGENE today to design your custom CRISPR model for regulation of cell growth research.
Frequently Asked Questions About regulation of cell growth
What is GO:0001558 regulation of cell growth?
GO:0001558 is a Gene Ontology biological process term defined as any process that modulates the frequency, rate, extent or direction of cell growth.
What genes are involved in regulation of cell growth?
Key genes include YAP1, WWTR1, STK3/4, LATS1/2, WNT11, STK11 (LKB1), FGFR, and EGFR, among others [1,5,6,7].
How does the Hippo pathway regulate cell growth?
The Hippo pathway phosphorylates and inactivates YAP/TAZ, thereby restricting cell growth and promoting contact inhibition.
What diseases are associated with dysregulated cell growth?
Cancer, cardiac hypertrophy, developmental lens defects, and metabolic muscle disorders are linked to disrupted growth regulation [1,4,5,6,7].
What research methods are used to study regulation of cell growth?
CRISPR screens, RNA-seq, Ribo-seq, proteomics, live-cell imaging, and organoid models are commonly used [1,3,4,6,7].
How does Wnt11 regulate cardiac growth?
Wnt11 controls both physiological and pathological cardiac growth, and its dysregulation contributes to hypertrophy and heart failure.
What is the role of LKB1 in cell growth regulation?
LKB1 (STK11) regulates skeletal muscle development, metabolism, and muscle progenitor cell homeostasis by linking energy sensing to growth control.
How do growth factors regulate lens development?
Growth factor signaling through receptors such as FGFR controls proliferation, differentiation, and apoptosis during lens development.
Can CRISPR be used to study regulation of cell growth?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models enable causal dissection of growth-regulatory genes [1,5,7].
What is the evolutionary significance of cell growth regulation?
Studies in land plants such as bryophytes reveal conserved mechanisms of stem cell regulation in shoot apical cells, highlighting deep evolutionary conservation.
Conclusion
Regulation of cell growth (GO:0001558) is a fundamental biological process that integrates signaling, transcriptional, metabolic, and mechanical inputs to control cell and tissue size [1,3,5,6,7]. Its dysregulation underlies major human diseases including cancer, cardiac hypertrophy, and developmental disorders [1,4,5,6,7]. Advances in CRISPR-based models and multi-omics methods continue to illuminate the precise molecular mechanisms governing growth control [1,3,7]. EDITGENE supports researchers with comprehensive CRISPR services to accelerate discovery in this critical field.
References
- 1. Zhao B et al.. 2007. Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control.. Genes Dev 21(21):2747-61 PMID: 17974916
- 3. Liu X et al.. 2025. Interplay of ECM organization, ROCK signaling, and cell polarity drives mesothelium formation and lung growth.. Nat Commun 16(1):9610 PMID: 41168230
- 4. Vasudevan D et al.. 2015. Regulation of Cell Death by IAPs and Their Antagonists.. Curr Top Dev Biol 114:185-208 PMID: 26431568
- 5. Halmetoja E et al.. 2022. Wnt11 in regulation of physiological and pathological cardiac growth.. FASEB J 36(10):e22544 PMID: 36098469
- 6. Lovicu FJ et al.. 2005. Growth factor regulation of lens development.. Dev Biol 280(1):1-14 PMID: 15766743
- 7. Shan T et al.. 2017. Lkb1 regulation of skeletal muscle development, metabolism and muscle progenitor cell homeostasis.. J Cell Physiol 232(10):2653-2656 PMID: 28067405
- 8. Hata Y et al.. 2021. Fundamental mechanisms of the stem cell regulation in land plants: lesson from shoot apical cells in bryophytes.. Plant Mol Biol 107(4-5):213-225 PMID: 33609252
